Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 1
|
pp. 857–871
Treatment patterns and survival analysis in patients with unresectable stage III EGFR-mutated non-small cell lung cancer
Back to article
Figure 4
(4 of 6)
−
100%
+
Figure 4.
Overall survival between TKI alone and TKI+chemotherapy groups.
(
A
) The unmatched cohort. (
B
) The propensity score matching cohort.
Figure 4 — Treatment patterns and survival analysis in patients with unresectable stage III EGFR-mutated non-small cell lung cancer | Aging
